DEXCOM INC SG&A Expense 2009-2026 | DXCM
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is DEXCOM INC's current sg&a expense?
DEXCOM INC (DXCM) annual sg&a expense for 2025 was $1.29B, a 0.40% increase from 2024. DEXCOM INC sg&a expense for the quarter ending March 31, 2026 was $349.7M.
What was DEXCOM INC's sg&a expense in 2024?
DEXCOM INC annual sg&a expense for 2024 was $1.29B, a 8.47% increase from 2023.
What was DEXCOM INC's sg&a expense in 2023?
DEXCOM INC annual sg&a expense for 2023 was $1.19B, a 17.63% increase from 2022.
What is DEXCOM INC's 5-year sg&a expense CAGR?
DEXCOM INC sg&a expense grew at a compound annual growth rate (CAGR) of 15.87% from FY2020 to FY2025, going from $618.2M to $1.29B over 5 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+15.9%
FY2020
$618.2M
→
FY2025
$1.29B
0910111213141516171819202122232425
5 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.29B | +0.4% | 10-K |
| FY2024 | $1.29B | +8.5% | 10-K |
| FY2023 | $1.19B | +17.6% | 10-K |
| FY2022 | $1.01B | +24.3% | 10-K |
| FY2021 | $810.5M | +31.1% | 10-K |
| FY2020 | $618.2M | +19.9% | 10-K |
| FY2019 | $515.7M | +19.2% | 10-K |
| FY2018 | $432.8M | +23.9% | 10-K |
| FY2017 | $349.2M | +22.0% | 10-K |
| FY2016 | $286.2M | +44.5% | 10-K |
| FY2015 | $198.0M | +54.2% | 10-K |
| FY2014 | $128.4M | +52.5% | 10-K |
| FY2013 | $84.2M | +31.6% | 10-K |
| FY2012 | $64.0M | +25.2% | 10-K |
| FY2011 | $51.1M | +26.2% | 10-K |
| FY2010 | $40.5M | +15.1% | 10-K |
| FY2009 | $35.2M | - | 10-K |
Company: DEXCOM INCTicker: DXCMSector: HealthcareIndustry: Surgical & Medical Instruments & ApparatusView company profile →